
Establishing growth charts is one of the most important steps in establishing normal development standards and identifying possible patterns in human growth. The purpose of this study is to examine how well body surface area (BSA) and quantile regression (QR) percentiles perform in a Pakistani population. Using a dataset of 9906 adult Pakistani citizens from Multan and Bahawalpur, we established BSA growth charts by plotting QR percentiles versus age. The mean BSA is 0.00709±0.00003 (standard deviation). The 85th to 95th percentiles of the QR percentiles showed a diminishing trend in the age range of 5- to 25-year, followed by strong increases in the 25- to 40-year age range and a subsequent decline up to 55-year. BSA rises throughout early adulthood, stabilizes in the Middle Ages, and then declines in old age. The study’s conclusions have a big impact on how growth percentile curves are made for different physiological and pathological conditions. It is possible to create more precise continuous BSA QR percentile curves versus specified ages. Building growth reference curves for the majority of physiological and medical issues affecting children and adolescents may be accomplished using this study. With these curves at their disposal, practitioners will be better equipped to identify deviations from the typical development pattern and comprehend normal growth patterns. The findings of this study emphasize how crucial it is to use QR percentiles when creating BSA growth charts in Pakistani communities. This helps to create growth charts that are more precise and trustworthy for Pakistani children.
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia, affecting millions globally. Traditional medicinal plants, like Chrysophyllum albidum (African star apple), have been used for their purported health benefits, including anti-diabetic properties. This study investigated the antidiabetic effect of Chrysophyllum albidum pulp extract on streptozotocin-induced diabetic rats, providing scientific validation for its traditional use. This experimental study used a randomized control trial design involving streptozotocin-induced diabetic rats. The study was conducted in accordance with the guidelines for the care and use of laboratory animals. The study was carried out after ethical approval was obtained from University of Ilorin ethical review committee. Twenty-five (25) male Wister rats were grouped into five groups. Each group consisted of five animals. The rats were subjected to the following treatment: Group 1: Normal control (non-diabetic, received Water only) Group 2: Diabetic control group (streptozotocin-induced, received Water only) Group 3: Diabetic + Standard drug (metformin) Group 4: Diabetic + 100mg/kg Chrysophyllum albidum pulp extract Group 5: Diabetic + 200mg/kg Chrysophyllum albidum pulp extract. Fresh pulps of Chrysophyllum albidum were collected, authenticated, and sun-dried. The dried pulps were grounded into powdered form. To 250g of the powdered crude sample,500Ml of 100% ethanol was added. The mixture was sealed with foil paper and allowed to stand at room temperature for7 days with frequent. The mixture was sieved, strained and the marc (damp solid material) was pressed. The solvent extract was filtered using Whatman No 1 filter paper as fine solvent extract was obtained. After the induction of diabetes using streptozotocin, the rats were treated daily for two (2) weeks with Chrysophyllum albidum pulp extract and the standard drug. Blood glucose level was monitored at baseline, 2 days intervals (e.g., Day 1, Day 3, Day 5, up till day 13) using a glucometer. The set of data obtained in this study was analyzed using SPSS statistical software version 23.0. ANOVA was the statistical analysis method used for this project work. Results of the phytochemical screening of Chrysophyllum albidum pulp extract revealed the presence of alkaloids, tannins, flavonoids, terpenoids and phenols. However, saponins were found to absent. Phenols were observed to have the highest concentration (20.1 mg/g), followed by alkaloids (15.2 mg/g), then flavonoids (10.8 mg/g). Terpenoids were found to have the least concentration (2.3 mg/g) compared to all other phytochemicals present. The highest amount of insulin was secreted by experimental animals in the normal control group (15.2 µU/mL) throughout the period of treatment. Experimental animals in group 2 showed the lowest amount of insulin (5.4 µU/mL) produced during the entire period of treatment. The extract of Chrysophyllum albidum pulp demonstrated significant antidiabetic effects, improved insulin levels translating to preserved pancreatic health in the diabetic rats in this study. Comparatively, Chrysophyllum albidum pulp extract showed efficacy similar to metformin, highlighting its potential as a natural anti-diabetic treatment
Introduction: Data on the real-world use of Lyumjev®, ultra-rapid-acting insulin lispro, as a mealtime insulin for people with diabetes in Germany are limited. We aimed to describe children and adults with diabetes receiving Lyumjev® in routine care in Germany. Materials and Methods: This retrospective cohort study used data on patients with type 1 or type 2 diabetes who initiated Lyumjev® treatment between June 14, 2020, and December 31, 2023, from the multicenter diabetes perspective follow-up registry. Patients were grouped into cohorts by age and diabetes type. Demographics, clinical characteristics, comorbidities, details of treatment at Lyumjev® initiation, and antidiabetic treatment history were described by cohort at baseline. Selected characteristics and treatment details were described for cohorts and follow-up time points at which data for ≥25 patients were available. Results: In total, 485 patients were included: 106 children and 291 adults with type 1 diabetes and 88 adults with type 2 diabetes. These cohorts receiving Lyumjev® were generally similar to the respective diabetes Lyumjev® phase III clinical trial populations in terms of age, disease duration, body mass index, and glycated hemoglobin. In adults with type 1 diabetes followed up for 12-18 months, glycated hemoglobin was stable without an increase in prandial and overall insulin dose or hypoglycemic events. Conclusion: These data suggest that the clinical utility of Lyumjev® demonstrated in phase III clinical trials is reflected in a real-world setting in Germany.
Obesity and diabetes have emerged as global health crises, with their prevalence reaching epidemic proportions.With increasing food intake and sedentary lifestyles contributing significantly to the obesity epidemic, recent research has highlighted the critical role of gut microbiota in the development and progression of these metabolic disorders.The gut microbiome is increasingly recognized as a key player in obesity and diabetes through its involvement in food absorption, energy regulation, low-grade inflammation, and insulin resistance.This review paper explores the latest advancements in understanding the gut microbiota's role in the development of obesity and type 2 diabetes (T2D), also focusing on the therapeutic potential of modulating gut microbiota to mitigate the impacts of these metabolic diseases, elucidating the underlying mechanisms and implications for human health.